- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous HCP alleged Shire MSLs created “noise” about unlicensed Vyvanse (LDX), set targets and encouraged named-patient use; also raised repeated advisory boards.…
MSD challenged a Victoza detail aid using a composite endpoint. Panel found the prominent red “HbA1c<7% + weight loss + no hypos”…
Pharmacosmos alleged Vifor used exclusivity/non-compete clauses in HCP consultancy contracts, potentially creating improper ‘retainer’ arrangements. The Panel found Pharmacosmos hadn’t proven a…
A formulary-pack “Evidence Review” for Seebri Breezhaler claimed 180‑day mortality after COPD exacerbation was 33% and implied reducing exacerbations reduces mortality. PMCPA…
Novartis admitted Ophthalmology Times Europe (Sept 2013) carried Lucentis advertising on three pages after a publisher duplicated the back cover via a…
An events agency tweeted about a Gedeon Richter meeting, naming ulipristal acetate and use in fibroid patients. PMCPA ruled this advertised a…
Bayer sponsored a BJMA UK meeting in Bolton (July 2013) with a stand and speaker. Panel found the event was mainly social/cultural…
Anonymous HCP alleged MSD reps hovered near public screening and confidentiality was poor. Panel found no proof reps engaged with screening, but…
Complaint alleged disguised promotion of unlicensed alirocumab at a Barcelona meeting and an “exception” for a UK investigator. Panel found the UK…
A hospital grant (£50k) was ruled inappropriately linked to Advagraf use and poorly documented. The case escalated due to incomplete/misleading responses and…
Pfizer-funded gabapentin dispensing alerts on pharmacy systems were alleged to be disguised promotion for pregabalin and misleading. The PMCPA Panel found no…
A PV associate following up a Yellow Card report asked a pharmacy for patient contact details and DOB without consent, and was…
A “safety” dosing reminder letter for Navelbine was ruled promotional. The Panel found missing prescribing info and AE reporting, an unqualified indication,…
Anonymous complaint alleged Allergan engineered a training meeting, selected delegates and bypassed slide approval. Panel found no supporting evidence and accepted Allergan’s…
Complaint alleged Shire failed to disclose Resolor (prucalopride) clinical trial results per ABPI requirements. Panel found older trials pre-dated disclosure obligations and…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.